Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nuo Therapeutics Inc.

www.cytomedix.com

Latest From Nuo Therapeutics Inc.

Aldea raises $24m for alcohol detox, anemia drug

Aldea Pharmaceuticals will begin clinical trials in acute alcohol intoxication and Fanconi anemia for AD-6626, the company's lead drug candidate for aldehyde metabolism disorders, with $24m in Series B venture capital from new Russian and Chinese investors and existing US-based VC backers.

Metabolic Disorders Gastrointestinal

Deals Shaping The Medical Industry, October 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced August through September 2013.

BioPharmaceutical Medical Device

Medical Device Deals Update, September 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced August-September 2013.

Medical Device

Stroke candidate to feel brunt of Cytomedix restructure

Cytomedix is to downsize its R&D activities in a renewed focus on profitability, in what is its second reorganization in as many months.

Dermatology Wound Healing & Tissue Repair
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Medical Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Wound Healing & Tissue Repair
  • Alias(es)
  • AuTologous Wound Therapy Inc.
  • Cytomedix Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Nuo Therapeutics Inc.
  • Senior Management
  • David Jorden, Acting CEO
    Peter Clausen, PhD, CSO
  • Contact Info
  • Nuo Therapeutics Inc.
    Phone: (240) 499-2680
    207 Perry Pkwy.
    Ste. 1
    Gaithersburg, MD 20877
    USA
UsernamePublicRestriction

Register